Bart J. Verwer

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization.

Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization.

Journal: United European gastroenterology journal
Published: September 05, 2024

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Journal: Trials
Published: June 01, 2022

Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study.

Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study.

Journal: European journal of internal medicine
Published: September 23, 2020

Plasma Cathepsin D Activity Rather Than Levels Correlates With Metabolic Parameters of Type 2 Diabetes in Male Individuals.

Plasma Cathepsin D Activity Rather Than Levels Correlates With Metabolic Parameters of Type 2 Diabetes in Male Individuals.

Journal: Frontiers in endocrinology
Published: June 22, 2020

NAFLD is related to Post-prandial Triglyceride-enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction.

NAFLD is related to Post-prandial Triglyceride-enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 21, 2019

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

Journal: Alimentary pharmacology & therapeutics
Published: April 12, 2018

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.

Journal: Clinical and translational gastroenterology
Published: October 12, 2017

HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.

HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.

Journal: Genes and immunity
Published: October 15, 2014

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.

Journal: Scandinavian journal of gastroenterology
Published: August 16, 2014

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

Journal: Gastroenterology
Published: December 19, 2013

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.

Journal: Journal of hepatology
Published: April 03, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026